NAMPT overexpression reduced hepatic TG levels in ethanol-fed control mice but not in Sirt6-HepKO mice, indicating SIRT6 is also required for NAMPT’s effects on alleviating hepatic steatosis (Fig 6J). The gene discussed is NAMPT; the disease is fatty liver disease.